Ultrasound imaging of apoptosis: high-resolution non-invasive monitoring of programmed cell death in vitro, in situ and in vivo by Czarnota, G J et al.
The process of apoptosis has become central to the understanding
of the development of normal tissues, the carcinogenic process and
the response of tumours to anticancer agents (Berry et al, 1990;
Meterissian, 1990; Lowe et al, 1994; Luo et al, 1996; Fisher et al,
1997; Thatte and Dahanikar, 1997). Currently, methods for
detecting and monitoring this process are invasive and time-
consuming. Biopsied tissue must be stained and imaged using
fluorescent optical microscopy, for example (Gaurieli et al, 1992).
The result is that spatial maps of apoptosis in tissues cannot easily
be produced. In this study, we demonstrate that conventional high-
frequency ultrasound imaging techniques (Sherar et al, 1987;
Pavlin et al, 1987; Bérubé et al, 1992) are exquisitely sensitive to
the apoptotic process (Czarnota et al, 1997a; Czarnota et al, this
study). Real-time non-invasive measurement of apoptosis in living
tissues is now possible. We demonstrate that this imaging method
may be used in the laboratory to monitor the responses of cells to
chemotherapeutic agents that induce apoptosis (Berry et al 1990;
Meterissian, 1990; Lowe et al, 1994; Thatte and Dahanikar, 1997),
and to visualize the responses of tissues to anti cancer treatments,
such as photodynamic therapy (PDT) (Luo et al, 1996; Webber 
et al, 1996; Fisher et al, 1997). Specifically, apoptotic
cells and tissues exhibit up to a sixfold increase in ultrasound
backscatter amplitude in comparison to non-apoptotic counter-
parts. Additionally, the specific subcellular features that permit the
apoptotic phenomenon to be visualized have been identified in this
study and are related to the changes in the cellular nuclear material
that cells undergo during apoptosis, including chromatin conden-
sation (Allegra et al, 1997) and DNA fragmentation. Our use of
ultrasound imaging to detect apoptosis in tissues in response to a
specific treatment represents the first evidence of the use of a non-
invasive imaging modality to detect programmed cell death both
ex vivo and in vivo.
METHODS
Cell preparation
All cells were prepared for ultrasound imaging using an acute
myeloid leukaemia cell culture system (AML-3), an ideal model
for studying apoptosis. For any experimental time point or
condition, experiments were completed in quadruplicate. For each
experiment, approximately 1 ´ 109 cells were grown at 37°C in
300 ml a-minimal-media always from frozen stock samples.
To induce apoptosis, five batches of cells were exposed to
cisplatinum at 10 mg ml–1. This drug is a DNA intercalater that
causes a p53-dependent apoptosis in this cell line (Zamble and
Leopard, 1995; Czarnota et al, 1997a). Cells were treated with
cisplatinum for 0, 6, 12, 24 and 48 h. To confirm that apoptosis
was occurring, the 24-h sample was examined using light-
microscopy, gel-electrophoresis showing DNA laddering, and
trypan blue staining, confirming that approximately 95% of the
cells underwent apoptosis at this time point. Cells were washed in
phosphate-buffered saline (PBS) and counted to ensure equal
numbers of cells, and subsequently pelleted in flat-bottom cryo-
tubes at 800 g on a desktop swinging bucket centrifuge. All pellets
were approximately the same size, with a diameter of 1 cm and a
height of 1 cm.
To arrest cells in mitosis, effectively enriching the mitotic frac-
tion in the cell population, cells were treated with colchicine at a
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350 Victoria Street, Toronto, Ontario, Canada M5B 2K3concentration of 0.1 mg ml–1 for 0, 6, 12, 24 and 48 h. By inhibiting
microtubule formation this drug arrests dividing cells at the G2/M
checkpoint of the cell cycle, corresponding to metaphase of
mitosis (Dustin, 1980). In this cell culture system the maximal
enrichment of the mitotic population is an increase to approxi-
mately 30%.
To help characterize the effects of the drugs, cytometry was
carried out using nuclei from approximately 3 ´ 105 cells. Cells
were lysed after resuspension in 1 ml isotonic buffer (0.2%
Triton X-100 in PBS-citrate, 0.1 mg ml–1 RNAase, 0.05 mg ml–1
propidium iodide) to release the nuclei. This suspension was
strained through a fine-gauze mesh to remove cell debris.
Following a 30-min incubation at 4°C in the dark, the samples
were analysed on a Becton-Dickenson flow cytometer. A cell
cycle analysis program, CellFIT 2.01.2 (SOBR), was used to quan-
tify cells with respect to different cell cycle phases.
For investigations of DNA condensation, effects on ultrasound
backscatter, pellets of mitotically enriched cells were taken and
gently resuspended in 1 ml of PBS. As controls, samples were
treated with only DNAase I (Pharmacia) at concentrations of
5413 U ml–1 and 10 826 U ml–1 and only Triton X-100 (Sigma) at a
concentration of 0.1% (w/v). In order to permeabilize cells and
permit DNAase I to enter the cells, samples were exposed to both
DNAase I and Triton X-100 at the concentrations given above.
Digestions proceeded for 30 min at 37°C and were terminated by
adding EDTA to a final concentration of 15 mM. All samples were
assessed histologically.
Light microscopy and analysis
To confirm and investigate the morphology of cells at each
experimental condition, ultrasonically imaged and duplicate non-
imaged samples were saved for haematoxylin and eosin (H&E)
staining by fixing 12 h in 10% (w/v) formalin in buffered saline.
These cells were embedded in paraffin and processed as histo-
logical sections. No histological differences due to ultrasound
imaging were observed. Images of pellet cryosections were
obtained to confirm that no differences in packing were present
(Czarnota et al, 1997a).
Light and fluorescence microscopy was carried out using a
Zeiss Axioscope 20 (Carl Zeiss, Germany) coupled to a colour
Sony CCD camera. Images were recorded digitally on a IBM PC
using the Northern Eclipse Image Analysis Software 1.1 (EMPIX
Imaging Inc.).
Ultrasound imaging and backscatter analysis
All cell samples and animal tissue samples were imaged at room
temperature immersed in buffered isotonic saline using a custom
built high-frequency ultrasound instrument operating at 40 MHz
(Czarnota et al, 1997a; Sherar et al, 1987). Living animals were
imaged using high-viscosity ultrasound gel (ATL Inc., Reedsville,
PA, USA) over areas of skin. The focal depth of the instrument is
9 mm, its axial resolution is 38 mm and its lateral resolution,
limited by the ultrasound beam width, is 55 mm. The ultrasound
probe was positioned such that the focal zone was the same depth
in each imaged specimen. All images were digitally recorded and a
physical hard-copy was simultaneously produced.
The ultrasound backscatter amplitude for each time-point was
assessed in two manners. In the first method, pixel intensities were
transformed to relative ultrasound backscatter amplitudes by
multiplying the inverse of the transfer function of the electronics
of the ultrasound imaging instrument (Czarnota et al, 1997a). This
corresponds directly to the degree of ultrasound backscatter ampli-
tude. For each sample, measurements were made using 32 images,
each 64 ´ 64 pixels in size, cropped from the focal band of images.
In the second method A-scans, the individual line scans which are
processed to produce two-dimensional ultrasound images were
obtained and assessed. Such A-scans are also independent of the
instrument’s image processing and amplification processes and
their analysis is the subject of a future study. Since both methods
provided equivalent results the former was used since it provided
information in a visual format, did not require the lengthy collec-
tion of radio-frequency data, and could be more readily used with
live animal specimens.
PDT and fluorescence analysis
Male Fisher rats were treated with 12.5 mg kg–1 of Photofrin II
(QLT, Canada) injected intraperitoneally and were kept in a dark
environment for 24 h prior to irradiation. A 5.5 mm craniectomy
was then created in each side of the rat’s skull, avoiding mechan-
ical stress to the underlying cortex. This area was then treated
for 30 s using a red laser light with a wavelength of 632 nm and
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Figure 1 Results of ultrasound imaging of apoptotic cells. Each panel is a representative ultrasound scan of a pellet of acute myeloid leukaemia cells. The
bottom of each ultrasound scan is at the bottom of each frame. Pellets are immersed in buffered saline. From left to right, panels correspond to cells treated with
cisplatinum for 0, 6, 12, 24 and 48 h to induce varying degrees of apoptosis. A bar at the bottom right of the figure indicates the colour map used in this image,
the left of the bar indicating the colour that corresponds to pixel values of 0 and the right giving the colour that corresponds to a pixel value of 256. At 0, 6, 12,
24 and 48 h histological analysis indicated that 1.6, 2, 36, 87 and 93% of all cells showed nuclear fragmentation, respectively. At the 6-h time point, 72% of the
cells exhibited prominent nuclear condensation changing from a nuclear diameter 70% of the cellular diameter before addition of the drug, to a diameter 40% of
the cellular diameter at 6 hours. After the 6-h time point, 95% of all cells exhibited nuclear condensation or fragmentation. The speckle pattern is characteristic
of ultrasound images. The scale bar indicates 1 mma spot size of 3 mm in diameter. This spot size was selected in
order to be readily visualized in the 4-mm scan width of the ultra-
sound microscope next to an untreated region. Several treatment
irradiances were employed, including 1, 3, 5 and 17 J cm–2. To
minimize post-therapy cerebral swelling and still show a sufficient
response to therapy, 3 J cm–2 was selected for further study. The
optical power irradiance at the dural surface was 100 mW cm–2.
Animal surgery methods that were used are published elsewhere
(Jiang et al, 1997).
The animals were sacrificed at three time points: 1.5, 3 and 24 h
after the above PDT. The first two time points were chosen to
survey early treatment effects. The last time was chosen since
earlier experimentation seemed to suggest an accumulation of
cells arrested in relatively early stages of apoptosis 8 h post-apop-
tosis inducing therapy (Li et al, 1996). Equivalent results were
obtained whether the rat brains were formalin-fixed prior to ultra-
sound imaging in order to minimize degradation effects, or imaged
ultrasonically prior to fixation.
For general pathological analysis, rat brains were sectioned and
haematoxylin and eosin stained. To specifically assess for the
effects of apoptosis, an enzymatic method was used (which with
terminal-deoxynucleotidyl-transferase) labelled the 3¢-OH ends of
fragmented DNA with fluorescein-12-dUTP (Promega, Madison,
WI, USA) (Gaurieli et al, 1992). Since ultrasound analyses of the
24-h post-therapy specimen were most consistent with the highest
levels of putative apoptosis, this specimen was subjected to the
apoptosis labelling assay. As a positive control a PDT-untreated rat
brain section was treated with proteinase-K and DNAase I, at a
concentration of 1 mg ml–1 and incubated at room temperature for
10 min prior to staining sections. This method results in about
70–80% positive green-staining cells in the control section, but
may stain control cells more intensely that apoptotic cells. As a
negative control, contralateral sections of the PDT-treated rat brain
were used. Sections of the PDT-exposed rat brain were also stained
in this fashion. All sections were counterstained with propidium
iodide, which stains both apoptotic and non-apoptotic cells red
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Figure 2 (A) Results of relative ultrasound backscatter measurements for apoptotic and mitotically-enriched acute myeloid leukaemia cells. Relative
ultrasound backscatter amplitude is plotted against drug exposure time for cisplatinum-treated apoptotic cells (solid line) and colchicine-treated mitotically
enriched cells (dashed line). In the cisplatinum-treated cells, onset of nuclear fragmentation after nuclei have condensed (6 h) further increases the scatter from
2.92-fold to 5.83-fold that of untreated cells. (B) Results indicating nuclear condensation is directly associated with increased ultrasound backscatter. Ultrasound
backscatter amplitude measurements show that colchicine treated cells (+C) scatter ultrasound 2.83 ± 1.2 times greater than the non-treated cells (acute
myeloid leukaemia). Addition of Triton X-100 alone to the colchicine-exposed cells (+CT) did not change the backscatter. Adding DNAase alone to the cells only
slightly lowered the backscatter (+CD). Addition of DNAase and permeabilization with Triton X-100 (+CTD) lowered the ultrasound backscatter towards that of
the untreated cells. Results shown are for the higher of two DNAase concentrations used. The lower level generated backscatter results intermediate between
the backscatter for colchicine exposed cells and samples treated with the higher DNAase concentration. (C) Representative histological analyses of acute
myeloid leukaemia cells. From left to right panels correspond to untreated viable cells, cells treated with cisplatinum for 24 h (apoptotic), cells treated with
colchicine for 24 h (mitotically enriched) and mitotically enriched cells treated with an excess of DNAase I to digest condensed DNA. Control samples treated
with DNAase alone or permeabilizing agent alone are histologically equivalent to the mitotically enriched population. The untreated cells exhibited a diameter of
6.0 ± 0.8 mm and had nuclei which are circular in cross-section with a diameter of 4.5 ± 0.8 mm. The cisplatinum-treated apoptotic cells, shown at 24 h after
addition of drug, had a slightly larger diameter of 6.4 ± 0.8 mm and prominent fragmented nuclei. On average, each cells had 3.9 ± 2.1 nuclear fragments that
were 2.0 ± 1.8 mm in length and 1.3 ± 0.8 mm in width. The colchicine-treated mitotically enriched cells exhibited prominent mitotic figures. These cells were
6.2 ± 1.0 mm in diameter and had nuclear regions 4.3 ± 1.0 mm in mean diameter. After treating such mitotically enriched cells with permeabilizing agent and
DNAase, their histological appearance changed (right-most panel). The prominent nuclear staining of the colchicine-treated cells was no longer present and the
cells appeared more like untreated cells with respect to their staining characteristics. These cells were unchanged in size after exposure to DNAase; they had a
mean diameter of 6.2 ± 1.1 mm and had pink staining nuclear regions that were 4.4 ± 1.3 mm in mean diameter. All values given are ± 1 standard deviation. The
scale bar indicates 20 mmthroughout the cytoplasm. Slides of sections were visualized
immediately after staining. Microscopy was carried out as above
using a standard fluorescein filter set (520 ± 20 nm) and an appro-
priate filter (> 620 nm) to detect propidium iodide staining
respectively. Images of red and green fluorescence were captured
separately and combined to form composites. In order to analyse
the fluorescence levels within cells in the sections, a computerized
approach was used to crop cells after automatic contouring and to
quantitatively determine separate levels of red staining and green
staining within each cell. These integrated values were then
corrected by normalization for slightly different red and green
fluorescent background staining values. Image analysis was
carried out on IBM PC running Aldus Photostyler Version 2.0.
In rat skin experiments, skin from the dorsal posterior of the
animal was shaved. A 1 cm diameter area was exposed to 0, 8.5, or
17 cm–2 with an irradiance of 100 mW cm–2. Animals were kept in
a dark environment before and after treatment. Living animals
were imaged in a sedated state (Jiang et al, 1997) 24 h after treat-
ment. Skin biopsies were obtained and submitted for histological
analyses. Apoptosis in rat skin was easily visualized in H&E-
stained sections. Fluorescently-labelled sections were analysed
confirming the presence of apoptosis.
RESULTS
In order to demonstrate and characterize the efficacy of ultrasound
imaging at detecting apoptosis in an ideal setting, a cell-culture
system was utilized to permit carefully controlled experiments
(Czarnota et al, 1997a). Centrifuged cells visualized using a high-
frequency ultrasound device (Sherar et al, 1987) operating at
40 MHz and thus permitting higher resolution imaging in compari-
son to conventional ultrasound devices operating at much lower
frequencies, are shown in Figure 1. Individual cells cannot be
resolved at the operating wavelength of this instrument but we
demonstrate in this study that changes in ensembles of cells can
result in significant changes in ultrasound images. The results
presented in Figures 1 and 2 indicate that apoptotic cells scatter
ultrasound at a level approximately six times that observed with
non-apoptotic cells. The degree of scattering also exhibits an
approximate linear relation to the progression of apoptosis in terms
of nuclear condensation and fragmentation. The ultrasound
backscatter amplitude begins to increase as the cells’ nuclei
condense approximately two- to threefold in diameter over that of
nuclei in non-apoptotic cells. The backscatter signal continues to
increase to six times that obtained for normal cells with subsequent
apoptotic nuclear fragmentation. Representative histological
results presented in Figure 2 indicate that these cells undergo a
classic apoptotic response. Gross changes in morphology are
observable, including changes in the nuclear membrane, nuclear
condensation and nuclear fragmentation. We have demonstrated
previously that increases in ultrasound image backscatter with
apoptosis are due to such differences in cell morphology, and not
due to potential differences in cell packing (Czarnota et al, 1997a).
Due to the observed correspondence of apoptotic nuclear
condensation (Allera et al, 1997) and subsequent nuclear fragmen-
tation with changes in ultrasound images, we hypothesized that the
nuclear material in the cells was responsible for the increased
ultrasound backscatter. This hypothesis was tested using the same
cell culture system, but with the pharmaco-active agent colchicine
(Dustin, 1980), which resulted in condensed nuclear material in
the form of metaphasic chromosomes, but not fragmentation.
Ultrasound results are presented in Figure 2. Whereas
the ultrasound images of the apoptotic cells indicated a sixfold
increase in backscatter in comparison to normal cells, the mitotic
cells exhibited approximately a threefold increase in ultrasound
backscatter amplitude. This is in good agreement with the ultra-
sound levels observed at the 6-h time point after treatment with
cisplatinum where the apoptotic fraction of cells exhibits primarily
nuclear condensation. By 24 h after colchicine exposure, a
maximal cell cycle arrest was visualized histologically and indi-
cated by cytometric analysis to be approximately 30% – the
maximal mitotic fraction that the cell line exhibited in response to
colchicine.
In order to test whether the presence of condensed DNA is
necessary to produce increased ultrasound backscatter, a further
series of experiments was devised, the results of which are
presented in Figure 2B. These experiments tested the hypothesis
that if DNA condensation was responsible for the noted increase in
ultrasound backscatter upon exposure to colchicine, then enzymat-
ically removing the DNA condensation (using DNAase) should
reduce the ultrasound signal to that of untreated cells. Appropriate
controls and histological analyses were included to ensure the drop
Ultrasound imaging of apoptosis 523
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Figure 3 (A) Measurement of ultrasound backscatter amplitude for rat brain
treated with photodynamic therapy. Tissue was examined ex vivo 1.5, 3 and
24 h following photodynamic therapy. Results indicate increasing ultrasound
backscatter with time compatible with the accumulation of post-photodynamic
therapy apoptotic cells. Bars labelled – correspond to non-irradiated controls,
whereas bars labelled + correspond to treated samples. Error bars
correspond to 1 standard deviation. (B) Representative ultrasound image of
photodynamic therapy-treated brain tissue examined ex vivo. The left panel
corresponds to non-irradiated control tissue contralateral to the treated tissue
shown in the right panel. The cone-shaped yellow area of increased
ultrasound backscatter corresponds to the treated region. The tissue shown
was freshly excised 24 h after therapy and is not fixed. The contrast is
equivalent to that obtained with samples fixed for histology. The colour map
indicated by the bar below the right panel is the same as for Figure 1. The
scale bar indicates 1 mmin ultrasound backscatter signal towards that of the normal cells
were a result of the DNAase activity and not the activity of the
permeabilizing agent. Using two different concentrations of
enzyme, the ultrasound backscatter was found to drop towards a
level similar to that of the untreated cells consistent with the inter-
pretation that nuclear condensation is responsible for the increase
in backscatter.
To determine whether ultrasound imaging could be used to
detect apoptosis that occurred in vivo, we applied the technique to
monitor apoptosis ex vivo in an animal system that involved PDT.
This type of therapy has been demonstrated to induce apoptosis in
several tissues (Luo et al, 1996; Matsumoto et al, 1996; Webber et
al, 1996; Fisher et al, 1997; Portnoy et al, manuscript in prepara-
tion). In our study, PDT using Photofrin II, a haematoporphyrin
derivative, was applied in a rat model system. After an investiga-
tion of dose and time effects, tissue responses were monitored at
three separate time points. Ultrasound backscatter measurements
and ultrasound images obtained at the 24-h time point at the site of
therapy and in the non-irradiated contralateral side of an unfixed
freshly-excised brain are shown in Figure 3. Backscatter amplitude
measurements indicate that the 1.5-, 3- and 24-h post-PDT brain
areas exhibited a 2.1 ± 1.1-, 3.3 ± 1.6- and 3.7 ± 2.0-fold increase
in ultrasound backscatter, respectively in comparison to individu-
alized controls. The 24-h tissues were selected for histological
analysis since ultrasound results indicated a maximal amount of
apoptosis in this sample. Since scoring from H&E-stained brain
sections was determined to be too subjective in our hands, a
specific staining procedure, a TdT assay, was used to detect apop-
tosis (Gaurieli et al, 1992). Free DNA ends produced by apoptotic
chromatin fragmentation were labelled with a green fluorescent
stain and a propidium iodide counterstain was used to mark cyto-
plasm red. A simple computerized assay was utilized where the
calculated ratios of green to red staining intensity correlated with
the presence or absence of apoptosis. The treated brain section
showed two statistically significant populations of cells which
were clustered distinctly below and above the apoptotic threshold
value of 1 in terms of their green to red staining ratios. Using this
value the analysis indicated approximately 40% of the cells to be
apoptotic in the treated region (Figure 4). This level of ultrasound
backscatter increase corresponded well to cell culture experiments
which indicated comparable increases in ultrasound backscatter
with apoptosis.
To demonstrate the feasibility of detecting apoptosis in vivo
additional experiments were carried out in which a photosensitized
524 GJ Czarnota et al
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Figure 4 Representative results of fluorescence microscopy assays for apoptosis. Images in the left column show composite images of propidium iodide and
fluorescein fluorescence, whereas right column panels present histograms of the ratio of integrated green staining to integrated red staining for cells cropped
from fluorescence images. Images are background normalized. Top panels correspond to data for untreated rat brain – a negative control. Centre panels
correspond to a DNAase I-digested rat brain section serving as a positive control for end-stage apoptosis. The bottom panels correspond to the photodynamic
therapy-treated brain in the zone of high ultrasound backscatter. Approximately 40% of the cells exhibit green to red staining ratios consistent with the criterion
for apoptosis determined using the positive control sample. The level of green staining in the cells increases twofold after photodynamic therapy. The scale bar
indicates 20 mm. In the histograms triangles represent mean values and error bars correspond to one standard deviation
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yrat had areas of its skin exposed to activating laser light. Areas of
skin in a sedated live animal exposed to 0, 17, and 8.5 J cm–2,
shown in Figure 5, result in ultrasound backscatter levels that
corresponded with the dose of activating light. At doses of 0, 8.5,
and 17 J cm–2 measurements of ultrasound backscatter amplitude
from the epidermis were 12.8 ± 4.3, 32 ± 6.4 and 59.8 ± 17.0
respectively. This part of the skin, which scatters more promi-
nently than the underlying dermis, can be readily identified since
the resolution of the instrument axially is 40 mm. Histological
analyses revealed increasing levels of apoptosis with the dose of
activating light (Figure 5). Consistent with ultrasound levels indi-
cating a marked backscatter response at the epidermal surface, the
most prominent levels of apoptosis were exhibited in the super-
ficial cellular layers of the epidermis. Apoptotic cells were easily
visible with H&E staining, in contrast to the brain sections, and
their identity was confirmed using fluorescent staining for apop-
tosis. However, increased backscatter was also observed with
increasing dose from a less superficial zone consistent with the
papillary and reticular layers of the dermis. In this zone the cellular
components, fibroblasts and leucocytes, appear to undergo apop-
totic cell death with photodynamic therapy resulting in a disrup-
tion of the dermal layer. This may account for the increased
backscatter seen deep in the tissue, away from the apoptotic
cellular epidermis.
DISCUSSION
This study demonstrates for the first time that apoptosis in tissues
is detectable using high-frequency ultrasound imaging. In this
investigation, we have been able to demonstrate the ultrasonic
detection of apoptosis in specific instances in vitro, ex vivo and in
vivo. In the three experimental systems used in this study, acute
myeloid leukaemia cells, rat brain and skin tissue, results indicate
up to a 25 to 50-fold increase in ultrasound image intensity with
the induction of apoptosis.
The in vitro experiments implicate the cell’s nuclear chromo-
somal material as the major source of ultrasound scattering. This is
not necessarily surprising since in the chromosome, the funda-
mental repeating subunit of chromatin, the nucleosome (Czarnota
and Ottensmeyer, 1996; Czarnota et al, 1997b), is comprised of a
protein density of 1.3 g cm–3, and a DNA density of 1.7 g cm–3 in
approximately equal proportions. Some 25 million of the protein
units in combination with 2 m of DNA are packed into chromo-
somes which are approximately 6–8 mm in length when condensed
(van Holde, 1988). The process of nuclear condensation, which
takes place in the early stages of apoptosis (Allera et al, 1997),
similar to mitosis, compacts chromosomes from forms which are
distributed throughout most of the cell’s nucleus to more canonical
condensed forms. Other previous studies also support the postulate
that the cellular nuclear material is the major scatterer of high
frequency ultrasound (Bérubé et al, 1992; Hunt et al, 1995;
Czarnota et al, 1997a). Direct evidence providing strong support
for this hypothesis is presented in this study, where the induction
of DNA condensation and enzymatic degradation of condensed
DNA demonstrates such condensation to be sufficient and neces-
sary to obtain an increased ultrasound backscatter. However, in our
experiments the mitotically enriched population of cells never
exhibited as great an increase in ultrasound backscatter as did the
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Figure 5 Imaging of apoptosis in vivo. Top panels present the results of ultrasound imaging, whereas the bottom panels illustrate corresponding representative
histological results. From left to right panels correspond to rat skin imaged in vivo 24 h after exposure to 0, 8.5, and 17 J cm–2 of activating laser light. Any
discontinuities in the images are a result of motions in the living animal caused by its respiration. The colour map shown below the right panel is the same as
used in all other figures. The most prominent increase in the top panels occurs at the epidermal surface with increasing dose. The epidermal layer is easily
visualized in the left panel – it is the bright line at the top of the skin. An increase in the lower dermal region also occurs. Corresponding histology shows
prominent apoptotic cells with condensed and fragmented nuclei in the epidermal region in both the 8.5 and 17 J cm–2 samples. A disruption of the cellularity in
the dermal region below also occurs with dose. The scale bar in the ultrasound images represents 0.5 mm. The scale bar in the histological images represents
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apoptotic cells. Specifically, the late-phase apoptotic cells with
fragmented nuclei scattered ultrasound approximately twice as
much as the early-phase apoptotic cells, with only condensed
nuclei. This is consistent with the result that cells in early apop-
tosis, at 6 h after cisplatinum treatment, also scatter ultrasound less
than in later stages in which nuclei are fragmented. A plausible
reason for such increases is linked to the randomization of scat-
terer location (Hunt et al, 1995) within the cell, which would occur
with apoptotic nuclear condensation and fragmentation. In prelim-
inary simulations, the condensing of the nucleus, its fragmentation
and the spatial randomization of these nuclear components
increased the backscatter signal intensity by at least five times.
This increase is in agreement with the increases in ultrasound
backscatter determined experimentally for the apoptotic cells
exhibiting nuclear condensation or nuclear fragmentation.
This study also demonstrates the ultrasonic detection of apop-
tosis in tissues ex vivo and non-invasively in vivo. In this work,
PDT-treated brain tissue was examined ex vivo and the ultrasound
imaging technique was used to image skin tissue in vivo in a living
animal, treated to induce apoptosis. The role of PDT in inducing
apoptosis is currently under investigation. Clearly the effect is
toxic to brain tissue, but limited in terms of activation by laser
penetration to local regions grossly 8 mm3 in volume. Never-
theless, the ultrasound results in this study coupled with apoptosis-
specific fluorescent labelling and analysis of histological sections
supports a role for apoptosis in the response to PDT of brain tissue
and skin tissue in this experimental system, consistent with other
investigations (Luo et al, 1996; Matsumoto et al, 1996; Webber et
al, 1996; Fisher et al, 1997; Portnoy et al, manuscript in prepara-
tion). In our study the use of ultrasound imaging to detect apop-
tosis in response to treatment of tissue represents the first evidence
of such a modality detecting programmed cell death ex vivo and in
vivo induced in a living organism. Since most chemotherapeutic
agents are now recognized to induce apoptosis in tumours (Berry
et al, 1990; Meterissian, 1990; Lowe et al, 1994; Thatte and
Dahanikar, 1997) one may envisage the ultrasound imaging
method being used in the future as a rapid means of evaluating the
effects of such treatment regimens in vivo. The ultrasound imaging
approach demonstrated in this study, once proven in tumour-based
models, could potentially provide the clinician with direct and
quantitative non-invasive measures of cellular response immedi-
ately after chemotherapy, a promising alternative to the current
custom of assessing outcome after a complete course of treatment
is finished.
This report presents the results of our first study aimed at
detecting apoptosis in cells and non-tumour-bearing tissues. This
work demonstrates that high-frequency ultrasound imaging can
detect apoptosis induced by a variety of manners, including cyto-
toxic drug and photodynamic methods. The responses of tumours
to such therapies may be more complex than those visualized in our
idealized model systems and deserve separate study in regards to
ultrasound imaging. First, the cell line used in this study represents
an ideal situation to measure apoptosis due to the fact that a number
of toxic stimuli can induce a well characterized apoptotic response
(Czarnota et al, 1997a). This cell line was selected because facile
growth and experimental manipulation can readily provide
adequate bulk quantities of packed cells. The use of such cells was
selected as a crude approximation to the packed cells in tissues. We
also used a skin system to demonstrate that apoptotic tissue could
be detected in a living animal using high-frequency ultrasound
imaging. Ultrasound imaging is a relatively straightforward process
for the visualization of superficial regions, but clearly an alternative
approach would be necessary with subcutaneous tissues. This is
necessitated by the high attenuation of epidermal and dermal
tissues, which limits ultrasound penetration. Developments occur-
ring in transducer technology should soon permit high-frequency
transducers to be mounted on catheters or needles which could aid
in the imaging of subcutaneous structures. Lastly, the apoptotic
response in tumours to toxic agents and therapies may be more
difficult to monitor by ultrasound imaging in comparison to the
cell system used and the tissues investigated in our study. Unlike
our model systems, chosen deliberately for being relatively homo-
geneous, tumours are more heterogeneous in terms of consistency.
This heterogeneity arises out of angiogenesis, necrosis, infiltration
by mononuclear cells and the presence of stroma in addition to
viable tumour cells. Treatment of tumours would not only induce
apoptosis but cause necrosis and mitotic arrest, all of which could
potentially confound ultrasound image interpretation. Such issues
would have to be addressed before attempting to use the ultra-
sound detection of apoptosis in a clinical evaluation. One
promising possible manner that may help to distinguish between
necrotic, apoptotic and mitotic tissues would be to use spectral
analysis on the A-scan information used to form the B-scan images
shown in this study (Lizzi et al, 1986). Our preliminary analyses
show that this adjunct method is more sensitive to the subtle differ-
ences between such cell types (Kolios et al, in preparation).
In conclusion, high-frequency ultrasound imaging was used to
detect apoptosis induced by anticancer agents in vitro, and to visu-
alize programmed cell death ex vivo and in vivo. Experimental
evidence supports the basis for the ultrasonic detection of
programmed cell death to be the subcellular nuclear changes cells
undergo during apoptosis. The results indicate that such subcel-
lular structural changes have a profound influence on ultrasound
images and provide a framework for future experiments aimed at
demonstrating the possibility of rapidly and non-invasively moni-
toring the effects of chemotherapeutic agents and other anticancer
treatments using an ultrasound-based approach.
ACKNOWLEDGEMENTS
We thank Allan Fernandes, Yew Meng Heng, Arthur Worthington,
Kasia Harasiewicz, Karen Hahn and Matthew Skinner for tech-
nical assistance. We thank Dr Brent Zanke and Dr Iain Quirt for
helpful discussions. This work was supported by research awards
to GJC from the Faculty of Medicine, University of Toronto with
funds in part from the Medical Research Council of Canada.
Additional support was from funds from the MRC awarded to
JWH, and FPO, and from funds from the National Cancer Institute
of Canada awarded to MDS. MCK is a recipient of a University
of Toronto Open Doctoral Fellowship and an Ontario Graduate
Fellowship.
REFERENCES
Allera C et al (1997) The condensation of chromatin in apoptotic thymocytes shows
a specific structural change. J Biol Chem 272: 10817–10822
Berry MA, Behnke CA and Eastman A (1990) Activation of programmed cell death
(apoptosis) by cisplatin, other anti-cancer drugs, toxins and hyperthermia.
Biochem Pharmacol 90: 2353–2362
Bérubé LR, Harasiewicz K and Foster FS (1992) Use of a high frequency ultrasound
microscope to image the action of 2-nitroimidazoles in multicellular spheroids.
Br J Cancer 65: 633–640Ultrasound imaging of apoptosis 527
British Journal of Cancer (1999) 81(3), 520–527 © 1999 Cancer Research Campaign
Czarnota GJ and Ottensmeyer FP (1996) Structural states of the nucleosome. J Biol
Chem 271: 3677–3683
Czarnota GJ, Kolios MC, Vaziri H, Benchimol S, Ottensmeyer FP, Sherar MD and
Hunt JW (1997a) Ultrasound biomicroscopy of viable, dead and apoptotic
cells. Ultrasound Med & Biol 23: 961–965
Czarnota GJ, Bazett-Jones DP, Mendez E, Allfrey VG and Ottensmeyer FP (1997b)
High resolution microanalysis and three-dimensional nucleosome structure
associated with transcribing chromatin. Micron 28: 419–431
Dustin P (1980) Microtubules. Sci Am 243: 66–76
Fisher AMR, Danenberg K, Banerjee D, Bertino JR, Danenberg P and Gomer CJ
(1997) Increased photosensitivity in HL60 cells expressing wild-type p53.
Photochem Photobiol 66: 265–270.
Gaurieli Y, Sherman Y and Ben-Sasson SA (1992) Identification of programmed cell
death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol
119: 493–501
Hunt JW, Worthington AE and Kerr AT (1995) The subtleties of ultrasound images
of an ensemble of cells: simulation from regular and more random distribution
of scatterers. Ultrasound Med Biol 21: 329–341
Jiang F, Lilge L, Logie B, Li Y and Chopp M (1997) Photodynamic therapy of 9L
gliosarcoma with liposome-delivered photofrin. Photochem Photobiol 65:
701–706
Li YQ, Guo YP, Jay V, Stewart PA and Wong CS (1996) Time course of radiation-
induced apoptosis in the adult rat spinal cord. Radiother Oncol 39: 35–42
Lizzi F, Ostromogilsky M, Feleppa E, Rorke M and Yaremko M (1986) Relationship
of ultrasonic spectral parameters to features of tissue microstructure. IEEE
Transactions on Ultrasonics, Ferroelectrics, and Frequency Control 33:
319–329
Lowe SW, Boris S, McClatchey A, Remington L, Ruley HE and Jacks T (1994)
p53 status and the efficacy of cancer chemotherapy. Science 266: 807–810
Luo Y, Chang CK and Kessel D (1996) Rapid induction of apoptosis by
photodynamic therapy. Photochem Photobiol 63: 528–534
Matsumoto Y, Muro Y, Banno S, Okasaki M and Tamada Y (1996) Differential
apoptotic pattern induced by photodynamic therapy. Arch Derm Res 289:
52–54
Meterissian SH (1990) Apoptosis: its role in the progression of and chemotherapy
for carcinoma. J Am College Surg 184: 658–666
Pavlin CJ, Sherar MD and Foster FS (1990) Subsurface ultrasound microscopic
imaging of the intact eye. Ophthamology 97: 244–250
Sherar MD, Noss MB and Foster FS (1987) Ultrasound backscatter microscopy
images the internal structure of living tumour spheroids. Nature 330: 493–495
Thatte U and Dahanikar S (1997) Apoptosis: clinical relevance and pharmacological
manipulation. Drugs 54: 511–532
van Holde KE (1988) Chromatin. Springer-Verlag, New York
Webber J, Luo Y, Crihy R, Fromm D and Kessel D (1996) An apoptotic response to
photodynamic therapy with endogenous protoporphyrin in vivo. Photochem
Photobiol 35: 209–211
Zamble DS and Leopard CJ (1995) Cisplatin and DNA repair in cancer
chemotherapy. Trends Biochem Sci 20: 435–439